Expertise in
1
conditions

Dr. Samuel Sanchez-Rivera

Dermatology
Ponce, PR 
Expertise in
1
conditions
Ponce, PR 

Overview

Samuel Sanchez-Rivera is a Dermatologist practicing medicine in Ponce, Puerto Rico.

Dr. Sanchez-Rivera is highly rated in 1 condition, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Atopic Dermatitis, and Cutaneous Lupus Erythematosus (CLE).

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 8 clinical trials.

Graduate Institution

University Of Puerto Rico School Of Medicine

Specialties

Dermatology

Licenses

Dermatology in PR

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
First Medical Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Mapfre Insurance
  • INSURANCE PLAN
  • MEDICARE MAPD
Medical Card System
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MMM Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Plan De Salud Menonita
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

Ponce, PR 00716
Other Locations
Caguas, PR 00726
San Juan, PR 00911

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Drug
Study Drug: LY3454738
Study Phase: Phase 1
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3375880 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis: The ADmIRe Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3375880 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis: The ADmIRe Study
Enrollment Status: Terminated
Publish Date: April 20, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 7 Less Clinical Trials

1 Total Publications

A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement.
A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement.
Journal: Journal of the American Academy of Dermatology
Published: May 16, 2024
Similar Doctors
Expertise in
22
conditions
Dr. Tania M. Gonzalez-Santiago
Dermatology
Expertise in
22
conditions
Dr. Tania M. Gonzalez-Santiago
Dermatology

Laboratorio De Patologia Dr Noy

San Juan, PR 
 (46.2 miles away)
Languages Spoken:
English
See accepted insurances

Tania Gonzalez-Santiago is a Dermatologist practicing medicine in San Juan, Puerto Rico. Dr. Gonzalez-Santiago is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Bowen's Disease, Psoriasis, and Melanoma.

Expertise in
3
conditions
Dr. Luz D. Figueroa-Guzman
Dermatology
Expertise in
3
conditions
Dr. Luz D. Figueroa-Guzman
Dermatology

Recinto De Ciencias Medicas

Suite 200 Centro Comercial Rearto Metropolitano, Ave Americo Miranda, 
Rio Piedras, PR 
 (43.8 miles away)
787-758-7910
Experience:
47+ years
Languages Spoken:
English
See accepted insurances

Luz Figueroa-Guzman is a Dermatologist practicing medicine in Rio Piedras, Puerto Rico. She has been practicing medicine for over 47 years. Dr. Figueroa-Guzman is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Pemphigus Foliaceus, Pemphigus, Pemphigus Vulgaris, and Bullous Pemphigoid.

Expertise in
4
conditions
Dr. David G. Latoni-Maldonado
Dermatology
Expertise in
4
conditions
Dr. David G. Latoni-Maldonado
Dermatology
611 Calle Dr Pavia Fernandez Ste 101, 
San Juan, PR 
 (47.1 miles away)
787-268-1110
Languages Spoken:
English
See accepted insurances

David Latoni-Maldonado is a Dermatologist practicing medicine in San Juan, Puerto Rico. Dr. Latoni-Maldonado is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Ichthyosis Vulgaris, Malignant Hypertension, Female Pattern Baldness, and Parapsoriasis.

Frequently Asked Questions about Dr. Samuel Sanchez-Rivera

Is Dr. Samuel Sanchez-Rivera a top-rated expert for Plaque Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Samuel Sanchez-Rivera is classified as an Advanced expert for Plaque Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Samuel Sanchez-Rivera specialize in?

While Dr. Samuel Sanchez-Rivera is a Dermatology, they have specific expertise in Plaque Psoriasis, Psoriasis, and Atopic Dermatitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Samuel Sanchez-Rivera participate in research or clinical trials?

Yes. Dr. Samuel Sanchez-Rivera has published 1 articles and abstracts on conditions like Plaque Psoriasis. You can view a list of Dr. Samuel Sanchez-Rivera's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Samuel Sanchez-Rivera accept my insurance?

Dr. Samuel Sanchez-Rivera accepts most major insurance plans, including Blue Cross Blue Shield and First Medical Health Plan. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sanchez-Rivera's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile